Results- Financial Results For The Quarter Ended June 30, 2018
This is to inform that the Board of Directors, inter alia, approved the un-audited financial results of the Company for the quarter ended June 30, 2018 as recommended by the audit committee at their respective meeting(s) held today (August 9, 2018). Outcome of Board Meeting
In terms of Regulation 30, 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (August 9, 2018) had inter-alia approved the Un-audited Financial Results for the quarter ended June 30, 2018. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed.... Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith newspaper advertisement published in 'Financial Express' and 'Malai Sudar', both dated August 2, 2018 about intimation of Board Meeting scheduled to be held on August 9, 2018 to consider, approve and take on record the Un-audited Financial Results for the Quarter ended June 30, 2018. Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per Company's Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Promoters, Directors, Designated Employees, etc) from August 2, 2018 to August 12, 2018 (both days inclusive) for the purpose of meeting of the Board of Directors that is scheduled to be held on Thursday, August 9, 2018. Board Meeting Intimation for Board Meeting On August 9, 2018 (Thursday)
AMRUTANJAN HEALTH CARE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2018 ,inter alias, to consider and approve Un-audited Financial Results along with the Limited Review Report for the quarter ended June 30, 2018 Shareholding for the Period Ended June 30, 2018
Amrutanjan Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M SrinivasanDesignation :- Company Secretary and Compliance Officer Announcement under Regulation 30 (LODR)-Press Release / Media Release
Amrutanjan Health Care Limited has informed the exchange that the Company has received the 'GOLD Award from Reader's Digest in the Health and Personal Care Category'. Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for the Quarter & Year ended March 31, 2018 Corporate Action-Board approves Dividend
The Board of Directors recommended Final Dividend of Rs. 0.85 /- per equity share on 29230630 equity shares of Re. 1/- each fully paid up for the financial year 2017- 2018. The final dividend, if approved at the Annual General Meeting, will be paid to the eligible shareholders within 30 days of Annual General Meeting.